C07C 233/78
With the substituted hydrocarbon radical bound to the nitrogen atom of the
Official title: with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
C07C233/78 (With the substituted hydrocarbon radical bound to the nitrogen atom of the) appears on 217 US grants and 222 published applications in this corpus.
Search patents in C07C- Granted patents
- 217
- Published applications
- 222
- Assignees
- 173
- Inventors
- 846
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 7 | 0 |
| 1995 | 3 | 0 |
| 1996 | 9 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 7 | 0 |
| 2000 | 1 | 0 |
| 2001 | 8 | 2 |
| 2002 | 6 | 16 |
| 2003 | 6 | 6 |
| 2004 | 4 | 15 |
| 2005 | 4 | 9 |
| 2006 | 7 | 8 |
| 2007 | 13 | 17 |
| 2008 | 5 | 15 |
| 2009 | 8 | 6 |
| 2010 | 10 | 9 |
| 2011 | 2 | 1 |
| 2012 | 7 | 7 |
| 2013 | 2 | 4 |
| 2014 | 5 | 10 |
| 2015 | 8 | 9 |
| 2016 | 5 | 13 |
| 2017 | 9 | 17 |
| 2018 | 7 | 5 |
| 2019 | 7 | 8 |
| 2020 | 8 | 12 |
| 2021 | 6 | 11 |
| 2022 | 8 | 7 |
| 2023 | 5 | 4 |
| 2024 | 8 | 6 |
| 2025 | 2 | 4 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof14 Apr 2026US 12,599,599 B2Medicon Pharmaceuticals, Inc.
- Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof7 Oct 2025US 12,435,051 B2Vivozon Inc.
- Bicyclic CX3CR1 receptor agonists25 Mar 2025US 12,258,337 B2Board of Regents, The University of Texas System
- Diamine derivatives as inhibitors of leukotriene A4 hydrolase24 Dec 2024US 12,173,009 B2Celltaxis, LLC
- Ketone inhibitors of lysine gingipain8 Oct 2024US 12,110,263 B2Lighthouse Pharmaceuticals, Inc.
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
- Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase25 Sep 2025US 2025/0296935 A1Celltaxis, LLC
- Ketone inhibitors of lysine gingipain28 Aug 2025US 2025/0270162 A1Lighthouse Pharmaceuticals, Inc.
- Bicyclic cx3cr1 receptor agonists14 Aug 2025US 2025/0257057 A1Board of Regents, The University of Texas System
- Analogs of 4-bromo-2,5-dimethoxyphenethylamine13 Feb 2025US 2025/0049748 A1
Most cited
By later US patents
- Dense star polymers having core, core branches, terminal groups293US 4,507,466 AThe Dow Chemical Company · 1985
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Substituted aminomethyltetralins and their heterocyclic analogues81US 5,137,901 ABayer Aktiengesellschaft · 1992
- Multibinding inhibitors of microsomal triglyceride transferase protein58US 6,288,234 B1Advanced Medicine, Inc. · 2001
- Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules57US 5,773,236 AMolecule Probes, Inc. · 1998